Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Gynecologic 1

Conditions

Gestational Trophoblastic Disease 6Ovarian Neoplasms 2Teratoma, Ovarian 1Sarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1Liposarcoma 1Hydatidiform Mole, Invasive 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Choriocarcinoma 1Chondrosarcoma 1

Interventions

Doxorubicin 5Ifosfamide 4Filgrastim 4belinostat 2Radiotherapy 2Carboplatin 2saracatinib 1perifosine 1brostallicin 1Vincristine 1Trabectedin 1Topotecan 1Thiotepa 1Temozolomide 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Microscopy, Electron 1Mass Spectrometry 1Injections 1Imatinib Mesylate 1Fluorouracil 1Etoposide 1Epirubicin 1Dactinomycin 1Cyproheptadine 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1CYT-6091 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosarcoma × Dactinomycin × Gynecologic × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡